Dynavax partners on Valneva's SARS-CoV-2 vaccine candidate
September 15, 2020 -- Dynavax will supply its CpG 1018 adjuvant for use in Valneva's SARS-CoV-2 vaccine candidate, VLA2001, as part of a commercial partnership.
Takeda opens new cell therapy manufacturing facility
September 15, 2020 -- Takeda Pharmaceuticals said it has opened a new 24,000-sq-ft research and development (R&D) cell therapy manufacturing facility at its R&D headquarters in Boston.
Novus Therapeutics acquires Anelixis Therapeutics
September 15, 2020 -- Novus Therapeutics has completed the acquisition of Anelixis Therapeutics, including the lead clinical-stage compound AT-1501, a next-generation anti-CD40L antibody for the treatment of organ and cellular transplantation, autoimmune diseases, and neurodegenerative diseases.
Bristol Myers Squibb licenses cell therapy candidate from Obsidian
September 15, 2020 -- Bristol Myers Squibb has exercised an option to an exclusive worldwide license to a cell therapy candidate based on Obsidian Therapeutics' cytoDrive technology.
Hexagon Bio secures $47M to advance drug discovery platform
September 15, 2020 -- Hexagon Bio has closed $47 million in series A financing to advance its drug discovery capabilities on its fungal genomics-based platform.
Thermo Fisher expands plastics production to support COVID-19 efforts
September 15, 2020 -- Thermo Fisher Scientific is investing an additional $140 million to further expand its laboratory plastics consumables production to support the global need for COVID-19 testing, development, and manufacturing of therapies and vaccines.
Regeneron begins phase III trial of COVID-19 treatment in U.K.
September 14, 2020 -- Regeneron Pharmaceuticals and the University of Oxford have commenced a phase III clinical trial of potential treatments for COVID-19.
J&J calls for applicants for women in STEM award
September 14, 2020 -- Johnson & Johnson is now accepting applications for its 2021 women in STEM disciplines award.
Thermo Fisher center forms partnerships for biomarkers
September 14, 2020 -- Thermo Fisher Scientific announced new collaborations for clinical biomarker discovery among the Thermo Fisher Precision Medicine Science Center, AstraZeneca, and the University of Nebraska Medical Center.
GlycoT Therapeutics licenses glycoengineering tech to Daiichi Sankyo
September 14, 2020 -- GlycoT Therapeutics has signed a sublicense agreement for its glycoengineering technology with Daiichi Sankyo.
ESMO Virtual Congress 2020
September 14-29
2020 ACCP Annual Meeting
September 20-22
BioProcess International West
September 21-25
BioProcess International
September 21-25
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter